机器学习预测儿科药物不良反应使用共识衍生的稀缺数据
Yao Tian1, Jiacai Yi2, Kun Li1
1Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Communications chemistry
|December 25, 2025
概括
这项研究引入了一种新的计算方法,通过识别儿童的不良药物反应 (ADRs) 来提高儿科药物安全性. 这种方法增强了药物监测,解决了儿科医学中关键数据缺口.
科学领域:
- 药物监督 药物监督 药物监督
- 计算毒理学计算毒理学
- 儿科药理学 儿科药理学
背景情况:
- 药物不良反应 (ADR) 是儿童疾病和死亡的主要原因,儿童具有独特的发育脆弱性.
- 儿童药物安全研究面临挑战,原因是数据有限,依赖于以成人为中心的研究,造成了显著的证据差距.
研究的目的:
- 开发和验证儿科药物监测的综合计算方法.
- 改善对儿科特异性药物不良反应 (ADRs) 的鉴定,弥合现有的证据差距.
主要方法:
- 综合共识驱动的信号检测,多层次的生物特征和可解释的机器学习 (XGBoost).
- 利用140万份FDA不良事件报告系统报告创建了最大的儿科药物ADR数据集.
- 采用严重程度特定的门和通过四个算法 (PRR,ROR,BCPNN,EBGM) 进行投票,以优化ADR识别.
主要成果:
- 计算方法实现了显著的预测性能 (ROC AUC:0.7177),特别是在不平衡的数据集.
- 跨领域分析证实,成人衍生模型对儿科人口的概括性很差.
- 通过现有文献支持的已知和新的儿科特异性ADRs被确定.
结论:
- 开发的计算框架为儿科药物监测提供了方法上的创新.
- 这项工作解决了改善儿科患者药物安全数据的关键需求.
- 这些发现为儿童药物安全的临床和监管决策提供了实际的工具.
更多相关视频
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
1.2K
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
3.2K
相关概念视频
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
191
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191
01:12Analysis of Population Pharmacokinetic Data
648
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
648
01:29Drug Dosing: Infants and Children
229
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
229
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
225
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
225
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
133
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
133